While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With this in mind, we are always looking at value, growth, and momentum trends to discover great companies. Looking at the history of these trends, perhaps none is more beloved than value investing. This strategy simply looks to identify companies that are being undervalued by the broader market. Value investors use tried-and-true metrics and fundamental analysis to find companies that they believe are undervalued at their current share price levels. Luckily, Zacks has developed its own Style Scores system in an effort to find stocks with specific traits. Value investors will be interested in the system's "Value" category. Stocks with both "A" grades in the Value category and high Zacks Ranks are among the strongest value stocks on the market right now. One company value investors might notice is Afya (AFYA). AFYA is currently holding a Zacks Rank of #2 (Buy) and a Value grade of A. The stock is trading with P/E ratio of 9.79 right now. For comparison, its industry sports an average P/E of 20.49. Over the past year, AFYA's Forward P/E has been as high as 18.02 and as low as 8.83, with a median of 10.98. AFYA is also sporting a PEG ratio of 0.41. This popular figure is similar to the widely-used P/E ratio, but the PEG ratio also considers a company's expected EPS growth rate. AFYA's industry currently sports an average PEG of 1.21. Over the last 12 months, AFYA's PEG has been as high as 1.02 and as low as 0.39, with a median of 0.57. Another notable valuation metric for AFYA is its P/B ratio of 2.13. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. This company's current P/B looks solid when compared to its industry's average P/B of 3.45. Within the past 52 weeks, AFYA's P/B has been as high as 2.87 and as low as 1.90, with a median of 2.16. If you're looking for another solid Schools value stock, take a look at Adtalem Global Education (ATGE). ATGE is a # 2 (Buy) stock with a Value score of A. Shares of Adtalem Global Education currently holds a Forward P/E ratio of 11.70, and its PEG ratio is 0.78. In comparison, its industry sports average P/E and PEG ratios of 20.49 and 1.21. ATGE's Forward P/E has been as high as 13.86 and as low as 8.25, with a median of 10.25. During the same time period, its PEG ratio has been as high as 0.92, as low as 0.55, with a median of 0.68. Furthermore, Adtalem Global Education holds a P/B ratio of 1.91 and its industry's price-to-book ratio is 3.45. ATGE's P/B has been as high as 1.94, as low as 1.06, with a median of 1.43 over the past 12 months. These are just a handful of the figures considered in Afya and Adtalem Global Education's great Value grade. Still, they help show that the stock is likely being undervalued at the moment. Add this to the strength of its earnings outlook, and we can clearly see that AFYA and ATGE is an impressive value stock right now. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Afya Limited (AFYA):Free Stock Analysis Report Adtalem Global Education Inc. (ATGE):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Is Afya (AFYA) a Great Value Stock Right Now?
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...